[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ipharmacenter ipharmacenter ipharmacenter posts on X about $4503t, novartis, eli lilly, drugs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::982887414841556997/interactions)  - X Week XXXXX +903% - X Month XXXXX +14,356% - X Months XXXXX -XX% - X Year XXXXX +18% ### Mentions: X [#](/creator/twitter::982887414841556997/posts_active)  - X Week XX +367% - X Month XX +600% - X Months XX -XX% - X Year XX -XX% ### Followers: XXX [#](/creator/twitter::982887414841556997/followers)  - X Week XXX +0.78% - X Month XXX +0.78% - X Months XXX -XXXX% - X Year XXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::982887414841556997/influencer_rank)  ### Social Influence [#](/creator/twitter::982887414841556997/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [$4503t](/topic/$4503t) #5, [novartis](/topic/novartis) 14.29%, [eli lilly](/topic/eli-lilly) 7.14%, [drugs](/topic/drugs) XXXX% **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) [Eli Lilly and Company (LLY)](/topic/eli-lilly) ### Top Social Posts [#](/creator/twitter::982887414841556997/posts) --- Top posts by engagements in the last XX hours "#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:" [X Link](https://x.com/ipharmacenter/status/1979773804160364847) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-19T04:57Z XXX followers, XXX engagements "#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas" [X Link](https://x.com/ipharmacenter/status/1980534244800856314) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:18Z XXX followers, XX engagements "Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS" [X Link](https://x.com/ipharmacenter/status/1980540251014857177) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T07:42Z XXX followers, XXX engagements "Eli Lilly's orforglipron shines in Phase X trials for Type X Diabetes Great potential for a new oral treatment option. Read more about these promising results: #pharma #pharmaceutical #breakingnews #weightloss #revenues #Type2Diabetes #EliLilly" [X Link](https://x.com/ipharmacenter/status/1978705210009965010) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-16T06:10Z XXX followers, XX engagements "Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025" [X Link](https://x.com/ipharmacenter/status/1980674362329252263) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:35Z XXX followers, XX engagements "#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert" [X Link](https://x.com/ipharmacenter/status/1980675281460556163) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T16:39Z XXX followers, XX engagements "#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare" [X Link](https://x.com/ipharmacenter/status/1980695566947373389) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T17:59Z XXX followers, XX engagements "AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical" [X Link](https://x.com/ipharmacenter/status/1980696260467388675) [@ipharmacenter](/creator/x/ipharmacenter) 2025-10-21T18:02Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ipharmacenter ipharmacenteripharmacenter posts on X about $4503t, novartis, eli lilly, drugs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XX%
Social topic influence $4503t #5, novartis 14.29%, eli lilly 7.14%, drugs XXXX%
Top assets mentioned Novartis AG (NVS) Eli Lilly and Company (LLY)
Top posts by engagements in the last XX hours
"#AstraZeneca presenting multiple trial outcomes at #ESMO25 Fill the latest updates on @ipharmacenter #ESMO2025 updates here:"
X Link @ipharmacenter 2025-10-19T04:57Z XXX followers, XXX engagements
"#Xtandi Plus #Leuprolide Cuts Risk of Death by XX% in Advanced #ProstateCancer Delivering 8-Year Survival Benefit #ESMO25 #ESMO2025 #Pfizer #pharma #pharmaceutical #ESMOAmbassadors #Astellas"
X Link @ipharmacenter 2025-10-21T07:18Z XXX followers, XX engagements
"Find all #ESMO25 updates of major #pharmaceutical companies at one place on @ipharmacenter #ESMO2025 #ESMOAmbassadors #immunotherapy #pfizer #novartis #astrazeneca #johnsonandjohnson #astellas #merck #BMS"
X Link @ipharmacenter 2025-10-21T07:42Z XXX followers, XXX engagements
"Eli Lilly's orforglipron shines in Phase X trials for Type X Diabetes Great potential for a new oral treatment option. Read more about these promising results: #pharma #pharmaceutical #breakingnews #weightloss #revenues #Type2Diabetes #EliLilly"
X Link @ipharmacenter 2025-10-16T06:10Z XXX followers, XX engagements
"Several companies have provided updates for drugs that are in development for #bladdercancer at #ESMO25 #Roche presented data of #Tecentriq #Pfizer & #Merck presented the perioperative data of #Keytruda + #Padcev combination Find details here #ESMo2025"
X Link @ipharmacenter 2025-10-21T16:35Z XXX followers, XX engagements
"#Breastcancer updates at #ESMO2025 #AstraZenecas #Datroway showed survival benefit in TNBC #Enhertu showed benefits in eBC #Novartis #Kisqali showed disease recurrence in eBC #lillys #Verzenio showed long-term survival benefit #ESMO25 #OncoAlert"
X Link @ipharmacenter 2025-10-21T16:39Z XXX followers, XX engagements
"#Merck's #Keytruda shows meaningful survival benefits for an #immunotherapy-based approach in this challenging #ovariancancer population #ESMO2025 #ESMO25 #OncoAlerts #OncoAlert #Pharma #pharmaceutical #healthcare"
X Link @ipharmacenter 2025-10-21T17:59Z XXX followers, XX engagements
"AstraZeneca presented data Tecentriq with ctDNA testing. If approved it could mark a new era of precision medicine in bladder cancer management #ESMO25 #ESMO2025 #OncoAlert #Oncoalerts #ESMODailyReporter #cancer #pharma #pharmaceutical"
X Link @ipharmacenter 2025-10-21T18:02Z XXX followers, XXX engagements
/creator/x::ipharmacenter